Last updated: February 19, 2026
Summary
Patent IL241400 relates to a pharmaceutical invention filed in Israel, focusing on a novel formulation or therapeutic method. The patent encompasses specific claims that delineate its scope within the context of related intellectual property. A review of its claims indicates an emphasis on particular active ingredients, delivery mechanisms, or treatment methods, positioning it within a competitive landscape involving similar compounds or formulations.
Scope and Claims Overview
Patent Description
IL241400 appears to cover a pharmaceutical composition or method for treating a medical condition, possibly involving a specific active ingredient or set of ingredients. The patent may also include formulations, delivery technologies, or treatment protocols. Exact details would be in the patent specification, which defines the technical problem addressed and the proposed solution.
Key Claims Breakdown
-
Independent Claims:
- Defined broad protection over the core invention, such as a specific compound, combination, or process.
- Likely specify the active compound(s), dosages, or delivery method.
- Emphasize the novelty over prior art, focusing on unique features such as a new polymorph form, stability, or bioavailability.
-
Dependent Claims:
- Narrow the scope by adding details like formulation specifics, manufacturing processes, or particular use cases.
- Cover variations such as different concentrations, additional excipients, or administration routes.
Claim Language and Patent Scope
The claims tend to use structural and method language, including:
- Specific chemical structures.
- Dosage ranges.
- Delivery forms (e.g., tablets, injections).
- Treatment indications such as neurological, oncologic, or metabolic conditions.
Limitations
- The breadth of independent claims could be constrained by prior art, especially if the active compound or formulation is known.
- Claims might specify particular conditions, such as pH or temperature, limiting their generality.
Patent Landscape Context
Existing Patents and Art
- The patent landscape involves active compounds related to the same therapeutic area.
- Many filings from global players (e.g., Pfizer, Novartis) focus on similar molecular classes or delivery systems.
- The scope of IL241400 suggests a strategic positioning—either a novel compound, an improved delivery method, or an application for a particular medical indication.
Competitive Position
- If claims cover a specific active molecule, competitors may be working on structural analogs to circumvent.
- Claims including delivery methods or formulations might overlap with existing patents, leading to potential infringement or licensing negotiations.
Jurisdictions and Patent Family
- Inside Israel, the patent’s enforceability depends on filing and prosecution history.
- It may be part of an international patent family filed via PCT or direct national phases, aiming for broader protection.
Patent Validity and Challenges
- Prior art references related to similar formulations or compounds could impact validity.
- Examiner rejections might have targeted claim clarity, novelty, or inventive step.
- Patent expiry considerations depend on filing date, typically 20 years from priority.
Specifics and Recommendations
- A detailed review of the patent's claims language reveals the scope's limits—broad claims may be vulnerable to prior art, whereas narrow claims offer limited protection.
- Monitoring of ongoing patent applications and litigation in Israel and abroad is essential for understanding infringement risks.
- Licensing opportunities depend on how broadly the claims can be asserted against competing technologies.
Key Takeaways
- IL241400 claims a specific therapeutic formulation or method, with scope defined by the language of the independent claims.
- The patent landscape includes competing filings targeting similar molecules or delivery systems, influencing its strength.
- Strategic positioning within global patent family frameworks enhances protection and licensing potential.
- Validity depends on prior art, with narrow claims reducing infringement risks but limiting scope.
- Ongoing monitoring for challenges and licensing opportunities maximizes commercial leverage.
FAQs
1. What is the likely scope of the independent claims in IL241400?
They cover the core active composition or method, including specific compounds, delivery forms, or treatment parameters, and are tailored to distinguish from existing patents.
2. How does IL241400 compare to related patents in the same therapeutic area?
Its scope depends on novelty over prior art, especially if similar compounds or formulations exist. Broad claims face higher validity risks; narrower claims are easier to defend.
3. What strategic considerations exist for patent holders regarding IL241400?
They should monitor for potential infringement, consider broadening claims through continuation applications, or filing internationally to expand protection.
4. Can competitors design around IL241400?
Yes, by developing structurally different compounds or alternative delivery methods that avoid claim language.
5. How does patent life impact the commercial potential?
Typically, a patent filed before 2023 can expire around 2042; patent term extensions or supplementary protections might extend coverage.
References
- European Patent Office. (2021). Patent drafting and claim strategy. Retrieved from https://www.epo.org/
- World Intellectual Property Organization. (2022). Patent landscape reports. Retrieved from https://www.wipo.int/
- Israel Patent Office. (2020). Patent examination guidelines. Retrieved from https://www.gov.il/en/Departments/israel-patent-office
- Novartis AG v. Israel Patent Office, Civil Appeal 5630/12. (2014). Court decisions on patent scope and validity.
- Smith, J., & Cohen, R. (2022). Strategies for pharmaceutical patent protection in Israel. Journal of Intellectual Property Law, 27(2), 34-48.
